Immunovant (IMVT)
(Real Time Quote from BATS)
$15.07 USD
-0.33 (-2.14%)
Updated Sep 19, 2025 10:34 AM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IMVT 15.07 -0.33(-2.14%)
Will IMVT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IMVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMVT
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue?
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
IMVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy
Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?
Other News for IMVT
NR7 appears for IMVT after 1.92% move
Is IMVT building bearish momentum? 20 Day Moving Average Resistance shows up after declining 1.18%
IMVT forms 20 Day Moving Average Resistance on September 16
Is IMVT primed for downward momentum? Fell Below 20 Day Moving Average shows up after sinking 3.9%
Tracking Baker Brothers Portfolio - Q2 2025 Update